Fertility Friendly Low Testosterone Treatments: Best 2026

Best overall: treatment directed at the cause of low testosterone. Best for deficient reproductive hormone signaling: gonadotropin therapy. Best oral option to discuss for selected men: clomiphene. This 2026 guide compares fertility friendly low testosterone treatments without treating a higher testosterone level as proof of preserved fertility.

Why fertility changes the treatment decision

Testosterone replacement therapy is not a fertility-preserving default. Testosterone supplied from outside the body can suppress the hormonal signals that support sperm production. A better blood testosterone result does not establish that sperm production remains normal.

Alpha Hormones® is best suited to adults seeking individualized hormone evaluation with their fertility goals included in treatment planning. Tell the practice about current or future pregnancy plans before discussing prescriptions, including at your first visit to Alpha Hormones®.

The AUA/ASRM male infertility guideline advises against testosterone monotherapy for men interested in current or future fertility. That distinction drives this 2026 comparison: the appropriate option depends on why testosterone is low, whether sperm production is impaired and when you hope to conceive.

What makes the best fertility-friendly treatment?

A treatment belongs on your shortlist only when it fits the underlying problem. Use these criteria before comparing medication names:

• Confirmed diagnosis: Symptoms and consistently low testosterone need evaluation together. A single result is not enough.
• Hormone signaling: Luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH, help distinguish signaling problems from problems within the testes.
• Sperm production: Semen analysis evaluates fertility-related information that a testosterone blood test cannot provide.
• Pregnancy timeline: Trying now requires a different discussion from preserving options for later.
• Evidence and limitations: Some treatments have established roles in specific diagnoses; others are off-label options supported by more limited evidence.
• Monitoring: The plan must assess symptoms, safety and fertility-related results—not simply chase a testosterone target.

The Endocrine Society recommends confirming low testosterone with repeat morning fasting testing. This generally means 2 separate morning blood samples, interpreted alongside symptoms and clinical history.

Fertility-friendly options at a glance

These are treatment approaches to discuss with a clinician, not instructions to start medication. The ranking reflects distinct clinical situations rather than a universal winner.

The AUA/ASRM guideline allows clinicians to consider hCG, selective estrogen receptor modulators and aromatase inhibitors for infertile men with low serum testosterone. Its conditional recommendation reflects limited evidence, not equal suitability for every patient.

1. Cause-directed treatment: best for an identifiable contributor

Cause-directed treatment starts by asking why testosterone is low. Evaluation can include medication effects, metabolic health, relevant medical conditions and symptoms suggesting a pituitary or testicular problem.

For some men, addressing a contributing condition is more appropriate than immediately adding hormone medication. For others, the evaluation identifies a disorder that needs direct treatment or specialist care. Neither outcome should be assumed from symptoms alone.

Cause-directed treatment pros:

• Connects the treatment choice to a diagnosis.
• Addresses relevant health concerns beyond the testosterone result.
• Avoids automatically starting medication that suppresses sperm production.

Cause-directed treatment cons:

• Correcting a contributor does not guarantee normal testosterone or fertility.
• Lifestyle changes alone do not treat every hormonal disorder.
• Evaluation can identify several contributing problems rather than one simple cause.

Best for: Men whose assessment identifies a potentially treatable contributor to low testosterone.

Bring a complete medication and supplement list. Report prior testosterone or anabolic steroid use without minimizing it; that information changes how hormone and semen results are interpreted.

Verdict: Hold medication selection until the cause is evaluated. Cause-directed care is the strongest starting point, not a reason to delay necessary treatment indefinitely.

2. Gonadotropin therapy: best for deficient hormone signaling

Gonadotropin therapy has an established role in selected men with hypogonadotropic hypogonadism—a condition in which reproductive hormone signals are insufficient. Human chorionic gonadotropin, or hCG, acts similarly to LH and stimulates testosterone production within the testes.

FSH treatment can be added when needed to support sperm production. The exact approach depends on the diagnosis, previous development, hormone results and semen findings. An hCG prescription alone does not prove that fertility has been preserved.

Gonadotropin therapy pros:

• Addresses deficient reproductive hormone signaling directly.
• Can support sperm production in appropriate patients.
• Allows treatment decisions to follow both hormone and semen results.

Gonadotropin therapy cons:

• Usually involves injections and ongoing monitoring.
• Does not correct every form of testicular dysfunction.
• Response and the time needed for sperm production vary.

Best for: Men with confirmed deficient pituitary signaling who need fertility-focused treatment.

The important distinction in 2026 is between treating a signaling deficiency and adding hCG to an unrelated testosterone regimen. Those are not interchangeable treatment plans, and neither should be described as guaranteed fertility protection.

Verdict: Hold for specialist selection; discuss gonadotropin therapy when the diagnosis supports it. Men with significant sperm-production problems often need a reproductive urologist or another clinician experienced in male infertility.

3. Clomiphene: best oral option for selected responsive patients

Clomiphene is a selective estrogen receptor modulator, often shortened to SERM. It can increase the body's release of LH and FSH, which can raise endogenous testosterone when the relevant signaling pathway and testes can respond.

Clomiphene use for male low testosterone is off-label. That means the use is outside its FDA-approved indication; it does not mean every man with a low result is a suitable candidate.

Clomiphene pros:

• Offers an oral treatment approach.
• Stimulates endogenous hormone signaling rather than supplying testosterone directly.
• Can be considered when future fertility is part of the clinical decision.

Clomiphene cons:

• A higher testosterone result does not guarantee better semen parameters or pregnancy.
• It is not a solution for every form of testicular failure.
• Side effects can include visual symptoms, which require prompt clinical attention.

Best for: Selected men whose evaluation shows that stimulating their own hormone signaling is appropriate.

The AUA/ASRM guideline also cautions that SERM benefits for idiopathic male infertility are limited relative to assisted reproductive treatment. Raising testosterone and treating infertility are related questions, but they are not the same clinical endpoint.

Ask what result would justify continuing clomiphene and what would trigger a change. The answer should include your symptoms and fertility goals, not only a laboratory number.

Verdict: Hold until candidacy is established; consider clomiphene only with a defined monitoring plan.

4. Aromatase inhibitors: best for selected hormone patterns

Aromatase inhibitors reduce the conversion of testosterone to estradiol, a form of estrogen. Clinicians sometimes consider them when a man's hormone evaluation supports that approach.

Their use for male low testosterone or infertility is off-label. Estrogen is also important to men's health, including bone health, so lowering it indiscriminately is not a sound treatment goal.

Aromatase inhibitor pros:

• Offers an oral approach for selected patients.
• Targets a specific part of hormone metabolism.
• Can be considered without directly supplying testosterone.

Aromatase inhibitor cons:

• Evidence for fertility outcomes is limited.
• Excessive estrogen suppression can create health problems.
• Symptoms alone do not establish that this treatment is appropriate.

Best for: Men whose clinician identifies a hormone pattern that supports considering an aromatase inhibitor.

Do not select an estrogen-lowering medication because an online calculator labels a ratio undesirable. Results need interpretation with the laboratory method, medical history and treatment goal.

Verdict: Skip unless the clinical evaluation provides a specific reason to use it. An aromatase inhibitor is not a general-purpose addition to low-testosterone treatment.

How the options are ranked

The ranking prioritizes diagnosis fit, support for reproductive hormone signaling, fertility assessment and meaningful monitoring. It does not rank drugs by how quickly they raise a blood testosterone result.

For 2026 decisions, the clinical basis is the AUA/ASRM Diagnosis and Treatment of Infertility in Men guideline and the Endocrine Society's Testosterone Therapy in Men With Hypogonadism guideline. These sources address male infertility management and the diagnosis and treatment of testosterone deficiency, respectively.

The strongest default is therefore evaluation first, then a treatment matched to the cause. No medication on this list is a universal fertility guarantee.

What a fertility-focused evaluation should clarify

Clinical evaluation

Explain whether you are trying to conceive now, preserving options for later or uncertain about your timeline. Discuss symptoms, previous pregnancies, testicular history, relevant medical conditions and all hormone-related medication use.

Appropriate testing

Discuss repeat testosterone testing, LH and FSH, and semen analysis when fertility is a concern. Additional testing depends on the findings; every patient does not need the same panel.

Personalized planning

Agree on the treatment goal, the follow-up plan and the circumstances that warrant specialist referral. If the plan includes medication, ask how both safety and reproductive outcomes will be assessed.

A hormone consultation and a full male infertility evaluation serve different purposes. Ask whether you need coordinated care with a reproductive urologist, particularly when semen analysis is abnormal or pregnancy has not occurred.

When to seek fertility evaluation sooner

ASRM guidance generally recommends infertility evaluation after 12 months of trying when the female partner is younger than 35 years, or after 6 months of trying when the female partner is 35 years or older. Evaluation should begin sooner when a known condition suggests impaired fertility.

These timelines are not reasons to postpone care when low testosterone, prior hormone use or abnormal semen findings already raise a concern. Both partners' evaluations matter; focusing exclusively on testosterone can miss other barriers to pregnancy.

If you already take testosterone, contact the prescribing clinician before changing treatment. Discuss pregnancy timing, semen testing and whether specialist referral or sperm banking belongs in the plan. Banking sperm preserves a sample, not a guaranteed pregnancy.

Insurance is a separate question

Alpha Hormones® accepts many major PPO insurance plans and Original Medicare. Coverage and eligibility vary by plan.

Ask which visits, tests and proposed treatments qualify under your benefits before care begins. Acceptance of an insurance plan does not establish coverage for every fertility-related service, medication or referral.

Which treatment should you choose in 2026?

Choose the diagnostic pathway before choosing the drug. Cause-directed care is the default starting point; gonadotropin therapy, clomiphene and aromatase inhibitors each belong to narrower clinical situations.

For immediate pregnancy goals, prioritize semen assessment and appropriate fertility expertise. For future fertility, raise the issue before starting testosterone—not after a prescription has already been selected.

Alpha Hormones® provides individualized hormone care through clinical evaluation, appropriate testing, personalized planning and follow-up. Discuss whether your needs fit the practice's care or require coordination with a fertility specialist.

FAQ

One last thing

Ask how sperm production will be assessed before agreeing to a treatment described as fertility-friendly. A plan that follows only testosterone cannot answer the fertility question you came in with.

If you want to discuss low testosterone alongside your pregnancy goals, book an appointment for an individualized evaluation.

Related guides

• TRT costs and insurance explained